Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Guardiola

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancerX Pivot, A Awada, D Gedouin, et al.
British Journal of Cancer|December 17, 2011
Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic studyB Royer, E Kalbacher, S Onteniente, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2018
Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trialM Ignatiadis, S Litière, F Rothe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 27, 2016
A phase III trial of exemestane plus bevacizumab maintenance therapy in patients with metastatic breast cancer after first-line taxane and bevacizumab: a GINECO group studyO Trédan, P Follana, I Moullet, et al.
ESMO Open|May 13, 2025
Regorafenib combined with irinotecan as second-line treatment in metastatic gastro-oesophageal adenocarcinomas: results of PRODIGE 58-UCGI35-REGIRI Unicancer randomised phase II studyE Samalin, L Evesque, A Turpin, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancerX Pivot, A Awada, D Gedouin, et al.
British Journal of Cancer|December 17, 2011
Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic studyB Royer, E Kalbacher, S Onteniente, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2018
Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trialM Ignatiadis, S Litière, F Rothe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 27, 2016
A phase III trial of exemestane plus bevacizumab maintenance therapy in patients with metastatic breast cancer after first-line taxane and bevacizumab: a GINECO group studyO Trédan, P Follana, I Moullet, et al.
ESMO Open|May 13, 2025
Regorafenib combined with irinotecan as second-line treatment in metastatic gastro-oesophageal adenocarcinomas: results of PRODIGE 58-UCGI35-REGIRI Unicancer randomised phase II studyE Samalin, L Evesque, A Turpin, et al.
Pageof 5